EUVIMEDEUVIMED entdecken
Crossref

Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis

Jian Li, Anwaier Apizi, Tingting Song, Paiheriding Kamilijiang, Xiangyou Yu, Ruifeng Chai, Zhaoxia Yu iD

Journal of Interferon & Cytokine Research · 2025

DOI: 10.1089/jir.2025.0046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, 2025. Verfasst von Jian Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China. Hauptthemen laut MEDLINE: NF-kappa B, Sepsis, Tacrolimus Binding Proteins, Intestinal Barrier Function. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pro-apoptotic and pro-inflammatory effects of FK506 binding protein 5 (FKBP5) in sepsis-induced acute kidney injury have been previously reported. However, its biological functions and underlying mechanisms in regulating sepsis-induced intestinal injury remain elusive. Therefore, this study aimed to explore the effects of FKBP5 on sepsis-induced intestinal injury.

Methods

A mouse model of sepsis was established by cecal ligation and puncture (CLP). A cell model was established by treating Caco-2 cells with lipopolysaccharide (LPS). The impacts of FKBP5 knockdown on apoptosis, barrier integrity, inflammation, and the nuclear factor kappa B (NF-κB) signaling were evaluated in ileal tissue and Caco-2 cells.

Results

FKBP5 expression was elevated in the ileal tissue in response to CLP and LPS treatments. In mice with sepsis, FKBP5 knockdown reduced cell apoptosis and regulated Bax, Bcl-2, and cleaved PARP levels. FKBP5 knockdown also reduced the levels of D-lactic acid, tumor necrosis factor alpha, interleukin (IL)-6, and IL-1β, improved intestinal histopathological damage, and enhanced the expression of zonula occludens-1 and occludin. FKBP5 knockdown also displayed protective effects in LPS-stimulated cells. FKBP5 knockdown inhibited the NF-κB signaling in CLP and LPS groups.

Conclusion

Inhibition of FKBP5 alleviates inflammation and intestinal barrier dysfunction in sepsis, partially by inhibiting the NF-κB signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BSepsisTacrolimus Binding ProteinsIntestinal Barrier FunctionAnimalsMiceGene Knockdown TechniquesInflammationCaco-2 CellsHumansApoptosisSignal TransductionTacrolimus Binding Protein 5

Stichwörter der Autor:innen

FKBP5intestinal barrier dysfunctionsepsis

Substanzen

NF-kappa BTacrolimus Binding ProteinsTacrolimus Binding Protein 5

Autor:innen und Institutionen

  • Department of Critical Care Medicine, First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.

ORCID-Profile: Zhaoxia Yu

Zitieren

APA

Li, J., Apizi, A., Song, T., Kamilijiang, P., Yu, X., Chai, R., & Yu, Z. (2025). Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/jir.2025.0046

Vancouver

Li J, Apizi A, Song T, Kamilijiang P, Yu X, Chai R, et al. Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis. Journal of Interferon & Cytokine Research. 2025. doi:10.1089/jir.2025.0046

BibTeX
@article{Li2025,
  author = {Li, Jian and Apizi, Anwaier and Song, Tingting and Kamilijiang, Paiheriding and Yu, Xiangyou and Chai, Ruifeng and Yu, Zhaoxia},
  title = {Inhibition of FKBP5 Alleviates Inflammation and Intestinal Barrier Dysfunction in Sepsis},
  journal = {Journal of Interferon & Cytokine Research},
  year = {2025},
  doi = {10.1089/jir.2025.0046}
}
Kostenlos starten →